Drug Shortage Report for ZINC SULFATE INJECTION, USP
| Report ID | 267081 |
| Drug Identification Number | 02532972 |
| Brand name | ZINC SULFATE INJECTION, USP |
| Common or Proper name | ZINC SULFATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | ZINC |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 mL |
| ATC code | B05XA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-10-01 |
| Actual start date | 2025-10-01 |
| Estimated end date | 2026-01-03 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-10-02 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to a delay in production, we will be encountering a supply interruption on our Zinc Sulfate Injection, USP 1 mg/mL, 10 mL Vial effective October 1, 2025, until January 3, 2026. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-10-02 | English | Compare |
| v4 | 2025-09-30 | French | Compare |
| v3 | 2025-09-30 | English | Compare |
| v2 | 2025-09-12 | French | Compare |
| v1 | 2025-09-12 | English | Compare |
Showing 1 to 5 of 5